T. Seo

FRI0552 Sm04690, a wnt pathway inhibitor: anti-inflammatory and cartilage protective effects in preclinical oa models

C. Swearingen, Y. Yazici, V. Deshmukh, 2018, Osteoarthritis.

SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy

J. Hood, C. Barroga, Y. Yazici, 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.

B. Melchior, Ch Lai, J. Hood, 2019, Osteoarthritis and cartilage.

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

J. Hood, C. Barroga, M. Ibanez, 2018, Osteoarthritis and cartilage.

SAT 0604 AUTOLOGOUS BLOOD AND CORTICOSTEROID LOCAL INJECTION IN TREATMENT OF PLANTAR FASCIITIS ( RANDOMIZED , CONTROLLED MULTICENTER CLINICAL TRIAL )

Y. Yazici, B. Hofilena, M. Ibanez, 2022 .

Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis

C. Barroga, Y. Yazici, M. Ibanez, 2017 .

Experimental tendinopathy treatment with SM04755, a topical small molecule inhibitor of the WNT pathway

Y. Yazici, B. Hofilena, L. Dellamary, 2018 .

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

C. Barroga, M. Ibanez, B. Tam, 2018, Osteoarthritis and cartilage.

AB0070 LORECIVIVINT (SM04690), A POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS, DEMONSTRATED CARTILAGE-PROTECTIVE EFFECTS ON HUMAN OSTEOARTHRITIC EXPLANTS

D. D’Lima, W. Bugbee, S. Grogan, 2020, Annals of the Rheumatic Diseases.